India to Australia: Mesalamine Export Trade Route
India has recorded 11 verified shipments of Mesalamine exported to Australia, representing a combined trade value of $2.3M USD. This corridor is served by 2 active Indian exporters, with an average shipment value of $211.4K USD. The leading Indian exporter is SUN PHARMACEUTICAL INDUSTRIES LIMITED, which accounts for 97% of total export value with 10 shipments worth $2.3M USD. On the buying side, SUN PHARMA ANZ PTY LIMITED is the largest importer in Australia with $1.3M USD in purchases. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Australia Mesalamine corridor is one of India's established pharmaceutical export routes, with 11 shipments documented worth a combined $2.3M USD. The route is dominated by SUN PHARMACEUTICAL INDUSTRIES LIMITED, which alone accounts for roughly 97% of all export value, reflecting the consolidated nature of India's mesalamine manufacturing sector.
Across 2 active suppliers, the average shipment value stands at $211.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 81% of all shipments, consistent with mesalamine's non-urgent bulk-order profile.
Shipment activity peaks during April–June, with an average transit time of 15 days port-to-port. The route has recorded an annual growth rate of 15.3%, placing it at rank #20 among India's top mesalamine export destinations globally.
On the import side, key buyers of Indian mesalamine in Australia include SUN PHARMA ANZ PTY LIMITED, SUN PHARMA ANZ PTY LTD. SUN PHARMA ANZ PTY LIMITED is the single largest importer with 5 shipments valued at $1.3M USD.
Route Characteristics
- Average transit15 days
- Peak seasonQ2
- Primary modeSea freight
- Top portDELHI AIR
Market Position
- Global rank#20
- Annual growth+15.3%
- Demand growth+13.4%
- Regulatory ease85/100
Top 10 Indian Mesalamine Exporters to Australia
Showing top 10 of 2 Indian suppliers exporting Mesalamine to Australia, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | SUN PHARMACEUTICAL INDUSTRIES LIMITED Avg $225.5K per shipment | 10 | $2.3M | 97.0% |
| 2 | SUN PHARMACEUTICAL INDUSTRIES LTD Avg $70.7K per shipment | 1 | $70.7K | 3.0% |
This table shows the top 10 of 2 Indian companies exporting mesalamine to Australia, ranked by total trade value. The listed exporters are: SUN PHARMACEUTICAL INDUSTRIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LTD. SUN PHARMACEUTICAL INDUSTRIES LIMITED is the dominant supplier with 10 shipments worth $2.3M USD, giving it a 97% market share.
Top 10 Mesalamine Importers in Australia
Showing top 10 of 2 known buyers in Australia receiving Mesalamine shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian mesalamine in Australia include SUN PHARMA ANZ PTY LIMITED, SUN PHARMA ANZ PTY LTD. The largest importer is SUN PHARMA ANZ PTY LIMITED, accounting for $1.3M USD across 5 shipments — representing 55% of all mesalamine imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | SUN PHARMA ANZ PTY LIMITED | 5 | $1.3M | 54.9% |
| 2 | SUN PHARMA ANZ PTY LTD | 6 | $1.1M | 45.1% |
Top 10 Mesalamine Formulations Imported by Australia
Showing top 10 of 8 product formulations shipped on the India to Australia Mesalamine route, ranked by trade value
Australia imports a wide range of mesalamine formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — MESALAMINE DELAYED RELEASE TABLETS USP 1 — accounts for $771.3K USD across 3 shipments. A total of 8 product variants have been identified in the shipment records.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | MESALAMINE DELAYED RELEASE TABLETS USP 1 | 3 | $771.3K | 33.2% |
| 2 | MESALAMINE DELAYED RELEASE TAB.USP 1.2 G,PACK : BOT-120'S,Batch:DNG0143A MFD:11.02.2025 EXP:31.07.2026 etc. | 2 | $516.6K | 22.2% |
| 3 | MESALAMINE DELAYED RELEASE TABLETS USP 1.2 GBATCH : DNE0938A MFD : 20.08.2023 EXP : 31.01.2025 AS PER ATTACHED DOCUMENT | 1 | $286.6K | 12.3% |
| 4 | MESALAMINE DELAYED RELEASE TAB USP 1.2 G,Batch:DNF1150A,DNF1151A,DNF1152A,DNF1153A MFD:20.12.24,21.12.24,23.12.24,25.12. | 1 | $252.5K | 10.9% |
| 5 | MESALAMINE DELAYED RELEASE TABLETS USP 1.2G [4632 PACK 120'S BOTTLES] | 1 | $217.8K | 9.4% |
| 6 | MESALAMINE DELAYED RELEASE TABLETS USP 1.2 G (PACK : BOT-120S) | 1 | $139.4K | 6.0% |
| 7 | MESALAMINE DELAYED RELEASE TABLETS USP 1.2G [1547 PACK X120'S BOTTLES] (BATCH NO. DNF0320A MFG.DT. 04/2024; EXP. DT. 09/ | 1 | $71.0K | 3.1% |
| 8 | MESALAMINE DELAYED RELEASE TABLETS USP 1.2 G,BATCH : DNE0898A MFD : 10.08.2023 EXP : 31.01.2025 | 1 | $70.7K | 3.0% |
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 81%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
DELHI AIR handles the highest volume with 5 shipments. Transit time averages 15 days by sea.
Market Dynamics
India's mesalamine exports to Australia are driven primarily by a handful of large-scale manufacturers. SUN PHARMACEUTICAL INDUSTRIES LIMITED with 10 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 2 active exporters signals a competitive but concentrated market — buyers in Australia benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LTD — together account for 100% of total trade value on this route. The average shipment value of $211.4K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as mesalamine delayed release tab.usp 1.2 g,pack : bot-120's,batch:dng0143a mfd:11.02.2025 exp:31.07.2026 etc. and mesalamine delayed release tablets usp 1.2 gbatch : dne0938a mfd : 20.08.2023 exp : 31.01.2025 as per attached document , suggesting that buyers in Australia tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, SUN PHARMA ANZ PTY LIMITED is the largest importer with 5 shipments worth $1.3M USD — representing 55% of all mesalamine imports from India on this route.
Route Statistics
- Trade Volume
- $2.3M
- Avg. Shipment
- $211.4K
- Suppliers
- 2
- Buyers
- 2
- Transit (Sea)
- ~15 days
- Annual Growth
- +15.3%
Related Analysis
Other Mesalamine Routes
Unlock the Full India to Australia Mesalamine Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 11 shipments on this route.
Frequently Asked Questions — India to Australia Mesalamine Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Mesalamine to Australia?
The leading Indian exporters of Mesalamine to Australia are SUN PHARMACEUTICAL INDUSTRIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LTD. SUN PHARMACEUTICAL INDUSTRIES LIMITED holds the largest market share at approximately 97% of total trade value on this route.
Q What is the total value of Mesalamine exports from India to Australia?
India exports Mesalamine to Australia worth approximately $2.3M USD across 11 recorded shipments. The average value per shipment is $211.4K USD.
Q Which ports does India use to ship Mesalamine to Australia?
The most active port of origin is DELHI AIR with 5 shipments. Indian exporters primarily use sea freight for this route, with 81% of shipments going by sea and 27% by air.
Q How long does shipping take from India to Australia for Mesalamine?
The average transit time for Mesalamine shipments from India to Australia is approximately 15 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during April–June.
Q Is the India to Australia Mesalamine trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 15.3% with demand growth tracking at 13.4%. The route is ranked #20 among India's top Mesalamine export destinations globally.
Q How many suppliers are active on the India to Australia Mesalamine route?
There are currently 2 active Indian suppliers exporting Mesalamine to Australia. The market is moderately concentrated with SUN PHARMACEUTICAL INDUSTRIES LIMITED accounting for 97% of total shipment value.
Q Who are the main importers of Mesalamine from India in Australia?
The leading importers of Indian Mesalamine in Australia include SUN PHARMA ANZ PTY LIMITED, SUN PHARMA ANZ PTY LTD. SUN PHARMA ANZ PTY LIMITED is the largest buyer with 5 shipments worth $1.3M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Australia export trade corridor identified from Indian Customs (DGFT) records for Mesalamine.
- 2.Supplier/Buyer Matching: 2 Indian exporters and 2 importers in Australia matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 11 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
11 Verified Shipments
2 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists